Medical Library

i-NEB Mini™ 

• J.Samuel, G.Smaldone. Maximizing Deep Lung Deposition in Healthy and Fibrotic Subjects During Jet Nebulization. DOI: 10.1089/jamp.2019.1552 

i-AIRE™ 

• R.Toddywala, V.Shukla, A.Hande, G.Smaldone. Aerosol delivery of inhaled Vancomycin during mechanical ventilation using i-VENT™ System, a unique small volume, breath enhanced jet nebulizer. ISAM 2019 

• R.Toddywala, V.Shukla, A.Hande, G.Smaldone. Aerosol Delivery of Inhaled Drugs during Mechanical Ventilation using i-AIRE™ System, a Unique Small Volume, Breath Enhanced Jet Nebulizer. ATS 2020 

Interferon gamma 1b 

• R.Condos, W.Rom, N.Schluger. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-g via aerosol. Lancet. 1997 May 24;349(9064):1513-5. 

• Kim J, Ferrara G, Bao Y, Rom WN, Brown S, Condos R. Aerosol Interferon-gamma treatment in a group of patients with Idiopathic Pulmonary Fibrosis. . Am J of Respir and Crit Care Med 2003. 171:A346 

• R.Condos, F.Hull, N.Schluger, et al. Regional Deposition of Aerosolized Interferon-g in Pulmonary Tuberculosis. CHEST 2004; 125:2146-2155. 

• R.Dawson, R.Condos, D.Tse, et al. Immunomodulation with Recombinant Interferon-gamma1b in Pulmonary Tuberculosis. 2009. PLoS ONE 4(9): e6984. doi:10.1371/journal.pone.0006984. 

• K.Diaz, S.Skaria, K.Harris, et al. Delivery and safety of inhaled interferon-γ in idiopathic pulmonary fibrosis. J Aerosol Med Pulm Drug Deliv. 2012 Apr; 25(2):79-87. doi: 10.1089/jamp.2011.0919. 

• G.Smaldone, R.Condos. Interferon-γ and Idiopathic Pulmonary Fibrosis: Why Pulmonary Targeting May be an Answer. Respiratory Drug Delivery 2012, Vol 1, pp 39-50. 

• S.Skaria, J.Yang, R.Condos, G.Smaldone. Clinical Endpoints Following Inhaled Interferon in Idiopathic Pulmonary Fibrosis (IPF). J Aerosol Med Pulm Drug Deliv. 2013 Apr; 26(2):A49-A50. id: 335152.  

• N.MacIntyre, S.Bhardwaj, R.Toddywala. Aerosol Delivery of an Immunomodulator (Interferon – γ1b) within Mouse Lungs. ERS 2015 

• R.Toddywala, S.Bhardwaj, R.Condos, G.Smaldone. Aerosolized Treatments for Multi-Drug Resistant Tuberculosis: Pharmacokinetics of Selected Antibiotics following Lung Deposition in a Mouse Model. Parma 2015 (PK Poster) 

• R.Toddywala, S.Bhardwaj. Aerosolized Treatments for Multi-Drug Resistant Tuberculosis. Formulation and Aerosolized Delivery Characterization of Aminoglycoside and Fluoroquinolone –Class Antibiotics. Parma Formulation Poster 2015. 

• P.Kanth, C.Alaienia, G.Smaldone. Nebulized Mannitol, Particle Distribution, and Cough in Idiopathic Pulmonary Fibrosis. Respir Care 2018;63(11):1407–1412

• J Samuel, Smaldone, Maximizing Deep Lung Deposition in Healthy and Fibrotic Subjects During Jet Nebulization, J Aerosol Medicine and Pulmonary Drug Delivery, 33 (2) 2020, 108–115.